Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 478

BillFederalHouseIn Committee
Safe and Affordable Drugs from Canada Act of 2019
About This Bill
Committee
Latest Action · January 25, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
January 10, 2019
Cosponsors (15)
12D 3R
View PDF ↗

Summary

Highlight any text to annotate
Safe and Affordable Drugs from Canada Act of 2019 This bill requires the Food and Drug Administration (FDA)to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.